Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Perazella

Showing results (81-90 of 278) with videos related to

Pageof 28
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|December 9, 2016
Paraprotein-Related Kidney Disease: Attack of the Killer M ProteinsMark A Perazella, Kevin W Finkel,
Nature Reviews. Nephrology|March 26, 2014
Nephrotoxic effects of designer drugs: synthetic is not better!Randy L Luciano, Mark A Perazella
Seminars in Dialysis|June 9, 2007
Gadolinium use in patients with kidney disease: a cause for concernMark A Perazella, Roger A Rodby
The American Journal of Medicine|July 3, 2007
Gadolinium-induced nephrogenic systemic fibrosis in patients with kidney diseaseMark A Perazella, Roger A Rodby
Kidney International|August 14, 2009
Acute phosphate nephropathyGlen S Markowitz, Mark A Perazella
Clinical Nephrology|January 20, 2018
Update on the nephrotoxicity of novel anticancer agents
Eliezer Zachary Nussbaum, Mark A Perazella
Kidney360|May 18, 2022
Drug-Induced Osmotic Nephropathy: Add SGLT2-Inhibitors to the List?Mark A Perazella, Luis A Juncos
Clinical Kidney Journal|March 28, 2015
Crystalline-induced kidney disease: a case for urine microscopyRandy L Luciano, Mark A Perazella
The New England Journal of Medicine|March 8, 2023
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular RiskNestor Oliva-Damaso, Mark A Perazella
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|April 4, 2003
Renin-angiotensin-aldosterone system: fundamental aspects and clinical implications in renal and cardiovascular disordersMark A Perazella, John F Setaro
Pageof 28

Showing results (81-90 of 278) with videos related to

Sort By:
Pageof 28
Clinical Journal of the American Society of Nephrology : CJASN|December 9, 2016
Paraprotein-Related Kidney Disease: Attack of the Killer M ProteinsMark A Perazella, Kevin W Finkel,
Nature Reviews. Nephrology|March 26, 2014
Nephrotoxic effects of designer drugs: synthetic is not better!Randy L Luciano, Mark A Perazella
Seminars in Dialysis|June 9, 2007
Gadolinium use in patients with kidney disease: a cause for concernMark A Perazella, Roger A Rodby
The American Journal of Medicine|July 3, 2007
Gadolinium-induced nephrogenic systemic fibrosis in patients with kidney diseaseMark A Perazella, Roger A Rodby
Kidney International|August 14, 2009
Acute phosphate nephropathyGlen S Markowitz, Mark A Perazella
Clinical Nephrology|January 20, 2018
Update on the nephrotoxicity of novel anticancer agents
Eliezer Zachary Nussbaum, Mark A Perazella
Kidney360|May 18, 2022
Drug-Induced Osmotic Nephropathy: Add SGLT2-Inhibitors to the List?Mark A Perazella, Luis A Juncos
Clinical Kidney Journal|March 28, 2015
Crystalline-induced kidney disease: a case for urine microscopyRandy L Luciano, Mark A Perazella
The New England Journal of Medicine|March 8, 2023
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular RiskNestor Oliva-Damaso, Mark A Perazella
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|April 4, 2003
Renin-angiotensin-aldosterone system: fundamental aspects and clinical implications in renal and cardiovascular disordersMark A Perazella, John F Setaro
Pageof 28